PATENT CLAIM ANALYSIS

Application Number: 15936354
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["435", "007100"]

Abstract:
The present invention relates to biomarkers and diagnostic and prognostic methods for Alzheimer's disease and other neurodegenerative disorders. The invention also provides compositions for detecting the biomarker as well as compositions and methods useful for treating Alzheimer's disease and other neurodegenerative disorders.

Claim (Index 12):
A set of biomarkers for assessing neurodegenerative disorder status of a subject comprising one or more biomarkers, wherein the levels of the biomarkers in the set are assayed; and wherein the biomarker level determines the neurodegenerative disorder status of the subject with at least 40% specificity, wherein at least one or more of the set of biomarkers are selected from the group consisting of Tau, phosphorylated Tau, A\u00df1-42, TDP-43, \u03b1-synuclein, SOD-1, FUS, FKBP51, IRS-1, phosphorylated IRS-1, CTSD, LAMP1, UBP, HSP70, NSE, NFL, CD9, CD63, CD81, and CD171.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 90.0
- Lexical Diversity: 1.64286
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14522585', '15179761', '15878351', '15600959', '13807963']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6016265762153581
- 35 USC 102 Novelty (BERT): 0.6188433536331195
- Combined Prediction Score: 0.6033482539571342
- Mean Citation Score: 405.004586
- Max Citation Score: 652.3273
- Similarity Product: 481.5340601020217

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test